Hydrolase Enzymes Market Size, Share & Trends Analysis growing at a CAGR of 6.6% from 2022 to 2030

The global hydrolase enzymes market size was valued at USD 5.53 billion in 2021 and is projected to reach USD 9.82 billion by 2030, growing at a CAGR of 6.6% from 2022 to 2030. The key hydrolase enzymes are lipases, glycosidases, esterases, peptidases, nucleosidases, and phosphatases among others. The increasing prevalence of the product in the treatment of pancreatic insufficiency is expected to boost the demand in the forthcoming years.

Key Market Trends & Insights

• North America held the highest revenue share of 38.87% in 2021.
• Central & South America is expected to witness significant growth over the forecast period.
• Based on product, esterases dominated the hydrolase enzymes industry with the highest revenue share of 34.33% in 2021.
• In terms of application, food & Beverage dominated with the highest revenue share of 26.44% in 2021.

Market Size & Forecast

• 2021 Market Size: USD 5.53 billion
• 2030 Projected Market Size: USD 9.82 billion
• CAGR (2022-2030): 6.6%
• North America: Largest market in 2021

Request Free Sample Report: https://www.grandviewresearch.com/industry-analysis/hydrolase-enzymes-market-report/request/rs1

They help in treating several diseases on the account of their commercial availability, high stability, and catalytic efficiency. Hydrolase enzymes are used in the diagnosis of bone diseases, autoimmune & inflammatory diseases, cancer, diabetes, liver diseases, myocardial infarction, kidney disorder, pancreatitis, and skin disorders. The increasing occurrence of diseases and environmental pollution is expected to drive the utilization of hydrolase enzymes in diagnostics applications.

Hydrolase enzymes are utilized in the food & beverages industry to improve the quality of products and enhance their shelf life. They are used for making fruit juices to improve the quality of fruits and increase juice yields. With the advent of different technologies including genetic engineering, manufacturers have an option to produce the necessary quantity of hydrolase enzymes in selected production hosts such as transgenic plants and microorganisms. Market players are using appropriate microorganisms, such as enzyme-producing yeast, bacteria, and fungi for commercial-scale production.

The value chain depicts the backward integration of key players, whose business operations range from the manufacturing of raw materials to the distribution of finished products. Novozymes, BASF SE, DuPont Danisco, Associated British Foods plc, and DSM are the key players integrated across the value chain.

Fermentation technology is extensively used in the production of hydrolase enzymes. The technology includes the usage of microorganisms such as bacteria and yeast for hydrolase enzyme production. Products manufactured by using this technology are suitable for use in several specialty applications such as biochemistry, microbiology, therapeutics, diagnostics, structural biology, and biocatalysts. Technological breakthroughs are considered some of the prime factors supporting growth.

BASF SE and Novozymes are the key market players undertaking extensive R&D activities for the development of required enzymes for unexplored applications. As manufacturers are focusing on backward integration, the raw material supply is currently stable. However, with the entry of new players in the hydrolase enzymes market, the demand for hydrolase enzymes and raw material supply scenario is likely to negatively impact growth in the forthcoming years. 

Hydrolase Enzymes Market Report Scope